Eficacia y efectos adversos de la vacuna COVID-19 en embarazadas

Abstract

On January 20, 2020, the first case of COVID-19 in the Americas was reported in the United States and to date it has reached all fifty-four Member States with 23.2 million confirmed cases and 679,000 deaths. At the subnational level, several provinces of Ecuador documented a 3 to 10-fold increase in the number of cases reported in the last two weeks. Vaccination was one of the strategies to prevent complications, each of which presents adverse effects that can be frequent within the first two days after administration.

The objective of the research is to evaluate the efficacy and adverse effects of COVID-19 vaccine in pregnant women by means of a non-experimental narrative literature review with the search of updated articles of scientific quality Q1-Q4 published in databases such as Scopus and PubMed, applying bibliographic descriptors MESH, DESC, without discrimination of region, English and Spanish language, published within the last five years.

Although data are limited, women are more susceptible to coronavirus infection than the general population due to immunological changes during pregnancy. Administration of COVID-19 vaccines decreased the spread and complications. Although in most of the research conducted the administration of the Covid-19 vaccine is safe and beneficial for pregnant women, it is important to mention that each pregnant woman responds differently.